The Tiny Cargo Co., is a biotech startup producing nanosized drug delivery capsules (designated exosomes) that can be used to courier delicate molecules throughout the body. In collaboration with University of Virginia personnel, the firm has tackled evaluation of methods to load the exosomes with a new peptide drug candidate that is aimed at limiting the spread of damage after a heart attack, Usefully understood as providing a novel drug delivery system based on non-immunogenic bovine milk-derived exosomes for protected oral or IV-based delivery of potent therapeutics, the firm's approach may have the potenial of developing to use condition of treatment(s) of various conditions to include ischemic heart disease, gastrointestinal radiation disease, glioblastoma multiforme and other pathologies.
